Richard Schram, MD
Orthopedic Surgery · Austin, TXNPI 1548274913
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medinc Of Texas at 50.5% of the total. Reporting peaked in 2021 at $2,098 and has fallen 98.9% since, to $24 in 2025.
Across 30 payments — averaging $131.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medinc Of Texas$2K
- Zimmer Biomet$688
- Anika Therapeutics, Inc.$484
- Medtronic$246
- Heron Therapeutics, Inc.$154
- Smith+Nephew$137
- plus $249 from 8 others
What the payments were for
- Travel & lodging$1,08928%
- Food & beverage$86822%
- Education$1,99250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medinc Of Texas | 2 | $1,992 |
| Zimmer Biomet | 8 | $688 |
| Anika Therapeutics, Inc. | 1 | $484 |
| Medtronic | 4 | $246 |
| Heron Therapeutics, Inc. | 2 | $154 |
| Smith+Nephew | 4 | $137 |
| Nalu Medical, Inc. | 1 | $60 |
| Stryker | 2 | $52 |
| Catalyst Orthoscience | 1 | $41 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Abbott | 1 | $20 |
| Core Surgical Group | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA-Knee$537
- RevoMotion$484
- INTELLIS ADAPTIVESTIM$138
- Zynrelef$136
How this compares
$3,949 in reported general payments places this provider in the 60th percentile of 33 orthopedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 111 | $1,171 |
| Methylprednisolone | 87 | $586 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $540 |
| Diclofenac Sodium | 25 | $150 |
| Tramadol Hcl | 24 | $111 |
| Naproxen | 11 | $78 |
| Gabapentin | 22 | $75 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Austin
- Steven BrotzmanAustin$336K
- Rajesh ArakalPlano$79K
- Mark ScioliLubbock$70K
- John SimsAmarillo$35K
- Katherine LiHouston$19K
- Jason RamseyLubbock$13K
- Michael MarkowitzPlano$13K
- Mark GreenbergIrving$9K
- Bradley HarmanCleburne$7K
- David TemplinNew Braunfels$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.